UCB SA Chief Executive Officer Jean-Christophe Tellier said the success of its skin disease drug Bimzelx will allow the company to keep investing in the development pipeline.
www.bloomberg.com
#UCB #Forecasts #Record #Sales #Demand #Skin #Disease #Drug
UCB Forecasts Record Sales on Demand for Skin Disease Drug
